Exscientia
Latest round
- Series D
Last raised
- Apr 2021
Total raised
- $306M
Investors
- 13
About Exscientia
Based in Dundee, UK, and founded in 2012 by its CEO, Andrew Hopkins, Exscientia plc operates as a developer of therapeutic drugs using Artificial Intelligence (AI) and big data processes. The company has offices in Miami, Osaka, and Dundee. Exscientia plc has developed four more candidates that are now undergoing advanced profiling in preparation for IND submission in 2021. Exscientia trades on Nasdaq under the ticker symbol "EXAI". Exscientia plc uses AI to design and discover possible medicines. Exscientia plc's centaur chemist platform enables the development of productivity gains and approaches to ameliorate drug potency. The firm's product also outlines small molecules with dual pharmacology, as well as bi-specific small molecules managed by high-content phenotypic information. Exscientia plc has conducted drug discovery partnerships with Bristol-Myers Squibb, Sanofi, Bayer, Dainippon Sumitomo, and other biotech companies.
Who invested in Exscientia
13 investors across 3 rounds
See all investors in Exscientia
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Exscientia
Who invested in Exscientia?
Exscientia has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Exscientia raised?
Exscientia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Exscientia last raise money?
Exscientia's most recent round on record is a Series D, in Apr 2021.
What does Exscientia do?
Based in Dundee, UK, and founded in 2012 by its CEO, Andrew Hopkins, Exscientia plc operates as a developer of therapeutic drugs using Artificial Intelligence (AI) and big data processes.
Where is Exscientia headquartered?
Exscientia is headquartered in Oxford, UK.
Which VCs invest in companies like Exscientia?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Exscientia's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Exscientia? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.